Genes in this set(25):
| Std. name | Sys. name | SGDID |
| HIR1 | YBL008W | S000000104 |
| HHT1 | YBR010W | S000000214 |
| THI2 | YBR240C | S000000444 |
| PAF1 | YBR279W | S000000483 |
| RAD18 | YCR066W | S000000662 |
| RPN1 | YHR027C | S000001069 |
| NAP1 | YKR048C | S000001756 |
| GCN20 | YFR009W | S000001905 |
| MED2 | YDL005C | S000002163 |
| LHP1 | YDL051W | S000002209 |
| BRE1 | YDL074C | S000002232 |
| DPB4 | YDR121W | S000002528 |
| NGG1 | YDR176W | S000002583 |
| PGD1 | YGL025C | S000002993 |
| RAD6 | YGL058W | S000003026 |
| RTF1 | YGL244W | S000003213 |
| CAF130 | YGR134W | S000003366 |
| ASF1 | YJL115W | S000003651 |
| BUR2 | YLR226W | S000004216 |
| MFT1 | YML062C | S000004527 |
| HHT2 | YNL031C | S000004976 |
| CTR9 | YOL145C | S000005505 |
| HIR2 | YOR038C | S000005564 |
| LGE1 | YPL055C | S000005976 |
| NHP6A | YPR052C | S000006256 |
Enriched GO terms in this set:
GO:0005575 (cellular_component)
"The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together."
GO:0043226 (organelle)
"Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."
GO:0043227 (membrane-bound organelle)
"Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."
GO:0043231 (intracellular membrane-bound organelle)
"Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."
GO:0005634 (nucleus) [p < 0.001 (24/570: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent."
---
GO:0005575 (cellular_component)
"The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together."
GO:0044422 (organelle part)
"Any constituent part of an organelle, an organized structure of distinctive morphology and function. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, but excludes the plasma membrane."
GO:0044446 (intracellular organelle part)
"A constituent part of an intracellular organelle, an organized structure of distinctive morphology and function, occurring within the cell. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton but excludes the plasma membrane."
GO:0044428 (nuclear part) [p < 0.001 (17/304: HIR1; HHT1; PAF1; RAD18; MED2; LHP1; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; HHT2; CTR9; HIR2; NHP6A)]
"Any constituent part of the nucleus, a membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated."
GO:0005654 (nucleoplasm) [p < 0.001 (13/135: HIR1; PAF1; MED2; LHP1; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; CTR9; HIR2)]
"That part of the nuclear content other than the chromosomes or the nucleolus."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0009987 (cellular process)
"Processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."
GO:0016043 (cellular component organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of a cellular component; includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."
GO:0006996 (organelle organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell."
GO:0051276 (chromosome organization and biogenesis) [p < 0.001 (18/333: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A process that is carried out at the cellular level that results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0009987 (cellular process)
"Processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."
GO:0016043 (cellular component organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of a cellular component; includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."
GO:0006996 (organelle organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell."
GO:0051276 (chromosome organization and biogenesis) [p < 0.001 (18/333: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A process that is carried out at the cellular level that results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information."
GO:0006325 (establishment and/or maintenance of chromatin architecture) [p < 0.001 (15/137: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The specification, formation and maintenance of the physical structure of eukaryotic chromatin."
GO:0016568 (chromatin modification) [p = 0.001 (10/119: PAF1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1; NHP6A)]
"The alteration of DNA or protein in chromatin, which may result in changing the chromatin structure."
GO:0016569 (covalent chromatin modification) [p < 0.001 (8/55: PAF1; BRE1; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1)]
"The alteration of DNA or protein in chromatin by the covalent addition or removal of chemical groups."
GO:0016570 (histone modification) [p < 0.001 (8/55: PAF1; BRE1; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1)]
"The covalent alteration of one or more amino acid residues within a histone protein."
GO:0016574 (histone ubiquitination) [p < 0.001 (4/4: BRE1; RAD6; RTF1; LGE1)]
"The modification of histones by addition of ubiquitin groups."
---
GO:0005575 (cellular_component)
"The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together."
GO:0044422 (organelle part)
"Any constituent part of an organelle, an organized structure of distinctive morphology and function. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, but excludes the plasma membrane."
GO:0044446 (intracellular organelle part)
"A constituent part of an intracellular organelle, an organized structure of distinctive morphology and function, occurring within the cell. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton but excludes the plasma membrane."
GO:0044428 (nuclear part) [p < 0.001 (17/304: HIR1; HHT1; PAF1; RAD18; MED2; LHP1; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; HHT2; CTR9; HIR2; NHP6A)]
"Any constituent part of the nucleus, a membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated."
GO:0031981 (nuclear lumen) [p < 0.001 (13/171: HIR1; PAF1; MED2; LHP1; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; CTR9; HIR2)]
"The volume enclosed by the nuclear inner membrane."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0008152 (metabolic process) [p = 0.003 (25/1052: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"Processes that cause many of the chemical changes in living organisms, including anabolism and catabolism. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation."
GO:0044237 (cellular metabolic process) [p = 0.001 (25/1018: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways by which individual cells transform chemical substances."
GO:0006139 (nucleobase, nucleoside, nucleotide and nucleic acid metabolic process) [p < 0.001 (23/568: HIR1; HHT1; THI2; PAF1; RAD18; NAP1; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids."
GO:0006350 (transcription) [p < 0.001 (15/222: HIR1; THI2; PAF1; MED2; BRE1; DPB4; PGD1; RTF1; CAF130; ASF1; BUR2; MFT1; CTR9; HIR2; NHP6A)]
"The synthesis of either RNA on a template of DNA or DNA on a template of RNA."
GO:0006351 (transcription, DNA-dependent) [p < 0.001 (14/208: HIR1; THI2; PAF1; MED2; BRE1; DPB4; PGD1; RTF1; CAF130; ASF1; MFT1; CTR9; HIR2; NHP6A)]
"The synthesis of RNA on a template of DNA."
GO:0006366 (transcription from RNA polymerase II promoter) [p < 0.001 (11/133: HIR1; THI2; PAF1; MED2; PGD1; RTF1; CAF130; MFT1; CTR9; HIR2; NHP6A)]
"The synthesis of RNA from a DNA template by RNA polymerase II (Pol II), originating at a Pol II-specific promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs)."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0009987 (cellular process)
"Processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."
GO:0016043 (cellular component organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of a cellular component; includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."
GO:0006996 (organelle organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell."
GO:0051276 (chromosome organization and biogenesis) [p < 0.001 (18/333: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A process that is carried out at the cellular level that results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information."
GO:0006325 (establishment and/or maintenance of chromatin architecture) [p < 0.001 (15/137: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The specification, formation and maintenance of the physical structure of eukaryotic chromatin."
GO:0016568 (chromatin modification) [p = 0.001 (10/119: PAF1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1; NHP6A)]
"The alteration of DNA or protein in chromatin, which may result in changing the chromatin structure."
GO:0016569 (covalent chromatin modification) [p < 0.001 (8/55: PAF1; BRE1; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1)]
"The alteration of DNA or protein in chromatin by the covalent addition or removal of chemical groups."
GO:0016570 (histone modification) [p < 0.001 (8/55: PAF1; BRE1; NGG1; RAD6; RTF1; ASF1; CTR9; LGE1)]
"The covalent alteration of one or more amino acid residues within a histone protein."
GO:0016571 (histone methylation) [p = 0.001 (5/16: PAF1; BRE1; RTF1; CTR9; LGE1)]
"The modification of histones by addition of methyl groups."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0009987 (cellular process)
"Processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."
GO:0016043 (cellular component organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of a cellular component; includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."
GO:0006996 (organelle organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell."
GO:0051276 (chromosome organization and biogenesis) [p < 0.001 (18/333: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A process that is carried out at the cellular level that results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information."
GO:0006325 (establishment and/or maintenance of chromatin architecture) [p < 0.001 (15/137: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The specification, formation and maintenance of the physical structure of eukaryotic chromatin."
GO:0006333 (chromatin assembly or disassembly) [p = 0.001 (8/66: HIR1; HHT1; NAP1; BRE1; DPB4; ASF1; HHT2; HIR2)]
"The formation or destruction of chromatin structures."
---
GO:0005575 (cellular_component)
"The part of a cell or its extracellular environment in which a gene product is located. A gene product may be located in one or more parts of a cell and its location may be as specific as a particular macromolecular complex, that is, a stable, persistent association of macromolecules that function together."
GO:0044422 (organelle part)
"Any constituent part of an organelle, an organized structure of distinctive morphology and function. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, but excludes the plasma membrane."
GO:0044446 (intracellular organelle part)
"A constituent part of an intracellular organelle, an organized structure of distinctive morphology and function, occurring within the cell. Includes constituent parts of the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton but excludes the plasma membrane."
GO:0044428 (nuclear part) [p < 0.001 (17/304: HIR1; HHT1; PAF1; RAD18; MED2; LHP1; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; HHT2; CTR9; HIR2; NHP6A)]
"Any constituent part of the nucleus, a membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated."
GO:0044451 (nucleoplasm part) [p < 0.001 (12/127: HIR1; PAF1; MED2; DPB4; NGG1; PGD1; RTF1; CAF130; ASF1; MFT1; CTR9; HIR2)]
"Any constituent part of the nucleoplasm, that part of the nuclear content other than the chromosomes or the nucleolus."
GO:0016591 (DNA-directed RNA polymerase II, holoenzyme) [p = 0.002 (5/19: PAF1; MED2; PGD1; RTF1; CTR9)]
"Large protein complex composed of the RNA polymerase core complex and a variety of other proteins including transcription factor complexes TFIIA, D, E, F, and H which are required for promoter recognition, and the Mediator subcomplex. Catalyzes the synthesis of eukaryotic pre-mRNA."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0008152 (metabolic process) [p = 0.003 (25/1052: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"Processes that cause many of the chemical changes in living organisms, including anabolism and catabolism. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation."
GO:0044237 (cellular metabolic process) [p = 0.001 (25/1018: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways by which individual cells transform chemical substances."
GO:0006139 (nucleobase, nucleoside, nucleotide and nucleic acid metabolic process) [p < 0.001 (23/568: HIR1; HHT1; THI2; PAF1; RAD18; NAP1; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids."
GO:0016070 (RNA metabolic process) [p < 0.001 (15/290: HIR1; THI2; PAF1; MED2; LHP1; BRE1; DPB4; PGD1; RTF1; CAF130; ASF1; MFT1; CTR9; HIR2; NHP6A)]
"The chemical reactions and pathways involving RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage."
GO:0006354 (RNA elongation) [p = 0.005 (6/39: HIR1; PAF1; RTF1; MFT1; CTR9; HIR2)]
"The extension of an RNA molecule after transcription initiation by the addition of ribonucleotides catalyzed by an RNA polymerase."
GO:0006368 (RNA elongation from RNA polymerase II promoter) [p = 0.002 (6/34: HIR1; PAF1; RTF1; MFT1; CTR9; HIR2)]
"The extension of an RNA molecule after transcription initiation at an RNA polymerase II-specific promoter by the addition of ribonucleotides catalyzed by RNA polymerase II."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0008152 (metabolic process) [p = 0.003 (25/1052: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"Processes that cause many of the chemical changes in living organisms, including anabolism and catabolism. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation."
GO:0043170 (macromolecule metabolic process) [p = 0.001 (24/905: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways involving macromolecules, large molecules including proteins, nucleic acids and carbohydrates."
GO:0043283 (biopolymer metabolic process) [p < 0.001 (24/737: HIR1; HHT1; THI2; PAF1; RAD18; RPN1; NAP1; GCN20; MED2; LHP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; CAF130; ASF1; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The chemical reactions and pathways involving biopolymers, long, repeating chains of monomers found in nature e.g. polysaccharides and proteins."
GO:0043412 (biopolymer modification)
"The covalent alteration of one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological polymer, resulting in a change in its properties."
GO:0006464 (protein modification process)
"The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification)."
GO:0043687 (post-translational protein modification)
"The covalent alteration of one or more amino acids occurring in a protein after the protein has been completely translated and released from the ribosome."
GO:0006512 (ubiquitin cycle)
"The cyclical process by which one or more ubiquitin moieties are added to (ubiquitination) and removed from (deubiquitination) a protein."
GO:0016567 (protein ubiquitination)
"The process by which one or more ubiquitin moieties are added to a protein."
GO:0006513 (protein monoubiquitination) [p = 0.005 (4/11: BRE1; RAD6; RTF1; LGE1)]
"Addition of a single ubiquitin moiety to a protein."
---
GO:0003674 (molecular_function)
"Elemental activities, such as catalysis or binding, describing the actions of a gene product at the molecular level. A given gene product may exhibit one or more molecular functions."
GO:0030528 (transcription regulator activity) [p = 0.006 (9/120: HIR1; THI2; PAF1; MED2; NGG1; PGD1; RTF1; CTR9; HIR2)]
"Plays a role in regulating transcription; may bind a promoter or enhancer DNA sequence or interact with a DNA-binding transcription factor."
---
GO:0008150 (biological_process)
"Those processes specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end."
GO:0009987 (cellular process)
"Processes that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."
GO:0016043 (cellular component organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of a cellular component; includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."
GO:0006996 (organelle organization and biogenesis)
"A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell."
GO:0051276 (chromosome organization and biogenesis) [p < 0.001 (18/333: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; PGD1; RAD6; RTF1; ASF1; BUR2; MFT1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"A process that is carried out at the cellular level that results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information."
GO:0006325 (establishment and/or maintenance of chromatin architecture) [p < 0.001 (15/137: HIR1; HHT1; PAF1; NAP1; BRE1; DPB4; NGG1; RAD6; RTF1; ASF1; HHT2; CTR9; HIR2; LGE1; NHP6A)]
"The specification, formation and maintenance of the physical structure of eukaryotic chromatin."
GO:0006333 (chromatin assembly or disassembly) [p = 0.001 (8/66: HIR1; HHT1; NAP1; BRE1; DPB4; ASF1; HHT2; HIR2)]
"The formation or destruction of chromatin structures."
GO:0031497 (chromatin assembly)
"The assembly of DNA, histone proteins, and other associated proteins into chromatin structure, beginning with the formation of the basic unit, the nucleosome, followed by organization of the nucleosomes into higher order structures, ultimately giving rise to a complex organization of specific domains within the nucleus."
GO:0006334 (nucleosome assembly) [p = 0.001 (4/9: HIR1; NAP1; ASF1; HIR2)]
"The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA."
GO:0006336 (DNA replication-independent nucleosome assembly) [p = 0.010 (3/5: HIR1; ASF1; HIR2)]
"The formation of nucleosomes outside the context of DNA replication."
---